We are live on ! Find out more
NCNA

NuCana

13 hedge funds and large institutions have $208M invested in NuCana in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more capital invested

Capital invested by funds: $159M → $208M (+$49.3M)

2.47% more ownership

Funds ownership: 21.01% → 23.48% (+2.5%)

0% more funds holding

Funds holding: 13 → 13 (0)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.28%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
2
Increased
6
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

NCNA Hedge Fund Activity: Q1 2019 in Review

13 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in NuCana (NCNA) for Q1 2019, worth a combined $208M — up 31% from $159M a quarter earlier.

Fund positioning in NCNA was balanced in Q1 2019: 2 funds opened new positions, 2 closed out, 6 added to existing stakes and 0 trimmed.

The largest buyer was Woodford Investment Management, adding an estimated $18.9M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $6.49M sold.

  • 13 institutional investors held NuCana (NCNA) as of Q1 2019, unchanged from Q4 2018.
  • Funds reported $208M of NuCana stock for Q1 2019, up 31% quarter-over-quarter.
  • 2 funds opened new NuCana positions in Q1 2019 and 2 closed out, a net change of 0 holders.
  • The largest NuCana buyer in Q1 2019 was Woodford Investment Management, an estimated $18.9M added.
  • The largest NuCana seller in Q1 2019 was PFM Health Sciences, an estimated $6.49M sold.

Based on aggregated 13F filings for Q1 2019.